Metab
- Manufacturer
- Apotheca Company
- Effective date
- 2022-11-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:47:31
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Ascorbicum acidum 6X, Cysteinum 9X, Manganum gluconate 10X, Alpha-ketoglutaricum acidum 12X, Fumaricum acidum 12X, Germanium sesquioxide 12X, Iodium 12X, Magnesium metallicum 12X, Natrum oxalaceticum 12X, Pulsatilla 12X, Thyroidinum suis 12X, Vanadium metallicum 12X.
OTC - PURPOSE SECTION
INDICATIONS: For the temporary relief of symptoms related to impoverished blood and oxygenation including headache, slow metabolism, joint pain, swollen glands, sweating, congestion, low blood pressure, and fatigue.
WARNINGS SECTION
WARNINGS: Keep out of reach of children. In case of overdose, contact physician or Poison Control Center right away.
If pregnant or breast-feeding, seek advice of a health professional before use.
Tamper seal: "Sealed for Your Protection." Do not use if seal is broken or missing.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Demineralized water, 25% Ethanol.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN. In case of overdose, contact physician or Poison Control Center right away.
INDICATIONS & USAGE SECTION
INDICATIONS: For the temporary relief of symptoms related to impoverished blood and oxygenation including headache, slow metabolism, joint pain, swollen glands, sweating, congestion, low blood pressure, and fatigue.
OTC - QUESTIONS SECTION
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DESBIO
NDC 57520-0964-1
HOMEOPATHIC
METAB
1 FL OZ (30 ml)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0964-1 | 2022-11-18 | C162847 | 48780-1 | 9d75b9d0-05a4-f424-e053-dadaa90a57ce | Metab |
| 57520-0964-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-05a4-f424-e053-dadaa90a57ce | Metab |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .ALPHA.-KETOGLUTARIC ACID | ACTIVE INGREDIENT | 8ID597Z82X | 1 | |
| ASCORBIC ACID | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| CYSTEINE | ACTIVE INGREDIENT | K848JZ4886 | 1 | |
| FUMARIC ACID | ACTIVE INGREDIENT | 88XHZ13131 | 1 | |
| GERMANIUM SESQUIOXIDE | ACTIVE INGREDIENT | 96WE91N25T | 1 | |
| IODINE | ACTIVE INGREDIENT | 9679TC07X4 | 1 | |
| MAGNESIUM | ACTIVE INGREDIENT | I38ZP9992A | 1 | |
| MANGANESE GLUCONATE | ACTIVE INGREDIENT | 9YY2F980SV | 1 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| SODIUM DIETHYL OXALACETATE | ACTIVE INGREDIENT | 6CA025Y4FG | 1 | |
| THYROID, PORCINE | ACTIVE INGREDIENT | 6RV024OAUQ | 1 | |
| VANADIUM | ACTIVE INGREDIENT | 00J9J9XKDE | 1 | |
| .ALPHA.-KETOGLUTARIC ACID | ACTIVE MOIETY | 8ID597Z82X | 1 | |
| ASCORBIC ACID | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| CYSTEINE | ACTIVE MOIETY | K848JZ4886 | 1 | |
| FUMARIC ACID | ACTIVE MOIETY | 88XHZ13131 | 1 | |
| GERMANIUM SESQUIOXIDE | ACTIVE MOIETY | 96WE91N25T | 1 | |
| IODINE | ACTIVE MOIETY | 9679TC07X4 | 1 | |
| MAGNESIUM | ACTIVE MOIETY | I38ZP9992A | 1 | |
| MANGANESE | ACTIVE MOIETY | 42Z2K6ZL8P | 1 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| THYROID, PORCINE | ACTIVE MOIETY | 6RV024OAUQ | 1 | |
| VANADIUM | ACTIVE MOIETY | 00J9J9XKDE | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Metab
- Ascorbicum acidum, Cysteinum, Manganum gluconate, Alpha-ketoglutaricum acidum, Fumaricum acidum, Germanium sesquioxide, Iodium, Magnesium metallicum, Natrum oxalaceticum, Pulsatilla, Thyroidinum suis, Vanadium metallicum,
- ASCORBIC ACID
- CYSTEINE
- MANGANESE GLUCONATE
- MANGANOUS CATION
- .ALPHA.-KETOGLUTARIC ACID
- FUMARIC ACID
- GERMANIUM SESQUIOXIDE
- IODINE
- MAGNESIUM
- SODIUM DIETHYL OXALACETATE
- DIETHYL OXALACETATE
- PULSATILLA VULGARIS
- THYROID, PORCINE
- VANADIUM
- WATER
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0964 | 57520-0964-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| CYSTEINE | K848JZ4886 | ACTIB |
| MANGANESE GLUCONATE | 9YY2F980SV | ACTIB |
| .ALPHA.-KETOGLUTARIC ACID | 8ID597Z82X | ACTIB |
| FUMARIC ACID | 88XHZ13131 | ACTIB |
| GERMANIUM SESQUIOXIDE | 96WE91N25T | ACTIB |
| IODINE | 9679TC07X4 | ACTIB |
| MAGNESIUM | I38ZP9992A | ACTIB |
| SODIUM DIETHYL OXALACETATE | 6CA025Y4FG | ACTIB |
| PULSATILLA VULGARIS | I76KB35JEV | ACTIB |
| THYROID, PORCINE | 6RV024OAUQ | ACTIB |
| VANADIUM | 00J9J9XKDE | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 690e4603-80df-41ca-bf69-7672d5ef445b | b5cb59c4-2e59-424b-8507-76ce0bd7b9ee | 2022-11-18 | Warnings | 690e4603-80df-41ca-bf69-7672d5ef445b b5cb59c4-2e59-424b-8507-76ce0bd7b9ee |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
